Acne clinical trials for children and teens
Medical name: Acne vulgaris · Skin
Also: California · Florida · Kentucky · Michigan
32 trials are recruiting, according to ClinicalTrials.gov.
Checked against the registry on 5 October 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Ages 9 Years to 11 Years · 15 sites · Bausch Health Americas, Inc.
Details and how to check if you qualify · NCT07524946 on ClinicalTrials.gov
Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne
Ages 12 Years to 17 Years · 0 sites · Sanofi
Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation
Ages 15 Years to 35 Years · 1 site · Foundation University Islamabad
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Ages 16 Years to no maximum · 0 sites · National University Hospital, Singapore
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
Ages 14 Years to 45 Years · 1 site · Eurofarma Laboratorios S.A.
Comparison of Topical Clascoterone and Adapalene for Mild Acne Vulgaris
Ages 12 Years to 35 Years · 0 sites · Khyber Teaching Hospital
Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital
Ages 15 Years to 49 Years · 1 site · Sohag University
Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe Acne Vulgaris
Ages 16 Years to no maximum · 0 sites · Università degli Studi di Brescia
1% Clascoterone Cream for the Treatment Acne Vulgaris
Ages 12 Years to no maximum · 0 sites · Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
Ages 9 Years to no maximum · 1 site · Integrative Skin Science and Research
Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris
Ages 15 Years to 40 Years · 1 site · Yohanes Firmansyah, dr, MH, MM
Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris
Ages 12 Years to no maximum · 1 site · Pham Ngoc Thach University of Medicine
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Ages 12 Years to 17 Years · 30 sites · Incyte Corporation
Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study
Ages No minimum to no maximum · 1 site · Venus Research Center
Facial Skin Microbiome in Patients With Moderate-to-Severe Acne Vulgaris Treated With Isotretinoin
Ages 16 Years to 35 Years · 1 site · Can Tho University of Medicine and Pharmacy
Evaluation of Serum Ceramides C16, C24, and Sphingosine-1-Phosphate (S1P) in Patients With Acne Vulgaris
Ages 15 Years to 40 Years · 0 sites · Sohag University
Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate
Ages 12 Years to 45 Years · 1 site · Sohag University
Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris
Ages No minimum to no maximum · 1 site · Badr University
An Observational Clinical Study to Evaluate the Efficacy of the CeraVe Skin Care Line
Ages 13 Years to no maximum · 0 sites · ChinaNorm
PMCF Investigation of Medical Device ChitoCare® Medical
Ages No minimum to no maximum · 2 sites · Primex ehf
The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment
Ages 13 Years to 45 Years · 1 site · Universitas Padjadjaran
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
Ages 13 Years to 30 Years · 19 sites · Centre Hospitalier Universitaire de Nice
Serum CXCL10 and CRP Levels in Patients With Acne Vulgaris in Correlation With Disease Severity
Ages 12 Years to 40 Years · 1 site · Assiut University
The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Salicylic Acid 0,5%, Zinc Lactate, Hyaluronic Acid and Spot Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Honokiol
Ages 15 Years to 50 Years · 1 site · Dr.dr.Irma Bernadette, SpKK (K)
Weekly Isotretinoin vs Tetracycline for Moderate Acne
Ages 12 Years to no maximum · 1 site · Medical University of South Carolina
HS ABSCESSES: I&D VS PUNCH DEBRIDEMENT
Ages 16 Years to no maximum · 1 site · Erasmus Medical Center
Global Healthcare Study on Hidradenitis Suppurativa
Ages 14 Years to no maximum · 1 site · Julia Tatjana Maul
Various Procedural Treatment Options for Post-acne Atrophic Scars
Ages 13 Years to 50 Years · 1 site · Sheikh Zayed Medical College
A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase
Ages 14 Years to 24 Years · 1 site · Pierre Fabre Dermo Cosmetique
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
Ages 12 Years to no maximum · 1 site · Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
Ages No minimum to 80 Years · 1 site · Peking Union Medical College
Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital
Ages No minimum to no maximum · 1 site · Nantes University Hospital
More: Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials
